Title

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results From a Phase 3 Trial, Future 2

Document Type

Abstract

Publication Date

June 2017

Department

Dermatology

Share

COinS